The quest to eliminate lung cancer as a global cause of death has taken a positive step forward with 1 million-milestone met of a 5-million lung health Artificial Intelligence (AI) commitment. This new proactive initiative casts a wider net to currently invisible and unprofiled global patient populations, innovating beyond traditional lung cancer screening profiles such as age and smoking history.
Laudio, an innovator in frontline leader solutions that drive efficiency and engagement for health systems, today announced that Memorial Hermann Health System is implementing Laudio’s platform to enhance employee efficiency and engagement.
In the ever-evolving landscape of pharmaceuticals, innovation has become a guiding force for companies toward a future where healthcare is not only ef…
Oscar Health, Inc., a leading healthcare technology company, is announcing this year’s recipients of its Culturally Competent Care (CCC) Grants. The initiative, which is a component of Oscar’s CCC Program, delivers financial and on-the-ground support to select organizations who provide access to care in underserved communities.
Evinova will operate as a separate health-tech business within AstraZeneca Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human experience-driven to serve clinical trial sponsors, clinical research organisations...
In a captivating interview held at Frontiers Health in Rome, Nicole Raleigh, web editor at Pharmaphorum, engages in a thought-provoking conversation w…
A team of researchers has developed an artificial intelligence system capable of assessing the motor performance of Parkinson's patients. This discove…
Klick Health today announced Genome Perspective, the first artificial intelligence (AI) tool to be developed by an advertising agency to expedite project planning and increase the efficiency and velocity of delivery to clients.
Elation Health, the clinical-first technology company powering innovation in primary care, today announced that Seth Cedars has joined the company as general counsel and Tom Natt joined as chief growth officer.
-Evidation — the company creating new ways to measure and improve health in everyday life — today announced a landmark partnership with Our Future Health, a national health research initiative and collaboration between the UK’s National Health Service (NHS), public health agencies, non-profits, and leading life sciences companies.